secwatch.observer — SEC 8-K summary
======================================

Issuer:     AETHLON MEDICAL INC (AEMD)
CIK:        0000882291
Form:       8-K
Filed at:   2026-02-23T23:59:59+00:00
Accession:  0001683168-26-001259
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aethlon Medical stockholders approve increase in authorized shares to 100M and equity plan amendment
--------------------------------------------------------------------------------

- Stockholders approved increase in authorized common shares from 6M to 100M (495,950 for, 58,624 against).
- Stockholders approved 2020 Equity Incentive Plan amendment adding 100,000 shares (291,835 for, 18,607 against).
- Five directors elected; Haskell & White LLP ratified as auditor for FY ending March 31, 2026.
- Approved issuance of up to 1.66M shares upon warrant exercise and ~368k shares upon warrant inducement (Dec 2025 agreements).
- All proposals passed; quorum of ~57% of outstanding shares represented.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882291/000168316826001259/0001683168-26-001259-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882291/000168316826001259/aethlon_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-001259

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer